Sponsor or institution

Clinical trials and research at Centre Hospitalier Esquirol

As of November 12, 2026, Find a Trial lists 6 clinical trials run by Centre Hospitalier Esquirol that are recruiting, in France. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Understanding repetitive behaviors in Alzheimer's disease — Limoges, New Aquitaine Recruiting Jul 29, 2026
Eco-anxiety and suicide risk in youth in France — Limoges Recruiting Dec 26, 2025
Sensory profile in adults with high intellectual potential — Limoges, New Aquitaine Recruiting Jul 18, 2025
Sensitivity to Sensory Cues in Eating Disorders — Limoges, New Aquitaine Recruiting Jun 22, 2025
Understanding sensory profiles of patients using a calming room — Limoges, New Aquitaine Recruiting Feb 21, 2025
Psychomotor therapy's effect on quality of life in depression — Limoges Recruiting Jan 31, 2024

All recruiting trials (6)

Quick answers

How many clinical trials run by Centre Hospitalier Esquirol are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in France. Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.